Skip to the main content.

Cybersecurity for Life Sciences

ICE for Life Sciences

Life Sciences companies play a crucial role in advancing human health and longevity. With unique technologies and development cycles, these companies face distinct cybersecurity challenges.

From early formation and lab development to large-scale clinical trials and commercialization, Life Sciences organizations evolve rapidly, often scaling quickly through investment rounds and, in some cases, IPO.

ICE has deep expertise in supporting Life Sciences companies at every stage of development across various industry segments.

Solutions for All Segments

Drugs and Biologics
Life Sciences companies focused on drug and biologic development have specific cybersecurity needs that evolve from IP protection in the lab to governance, partner management, and acquisition readiness. Managing development pipelines and processes with outsourced CROs (Contract Research Organizations) and CMOs (Contract Manufacturing Organizations) introduces particular cybersecurity requirements. ICE is uniquely positioned to address these needs, ensuring secure collaboration across the development lifecycle.

Devices and Diagnostics
Medical devices and diagnostic tools integrate software, mechanical, electrical, and cloud components, with patient safety on the line. Unlike typical consumer products, devices like insulin pumps are subject to stringent regulatory pathways, such as 510(k) and CLIA certifications. ICE provides cybersecurity support from testing and integration to software updates and monitoring, helping ensure that medical devices remain secure while allowing development teams to focus on patient outcomes.

Digital Therapeutics
Digital therapeutics offer a promising, non-invasive approach to addressing various health issues, from addiction and behavioral health to nutrition and social disorders. However, this sector also faces significant cybersecurity and privacy challenges, particularly around sensitive data involving behavioral health, minors, and substance abuse, which are governed by 42 CFR Part 2, exceeding the requirements of HIPAA and GDPR. ICE has extensive experience creating security programs tailored to these needs, enabling companies to focus on delivering impactful care.

Business-Science-Lab--Streamline-Cyber

ICE Differentiators for Life Sciences

Industry Experience
Decades of experience across hundreds of Life Sciences companies make ICE a trusted partner for cybersecurity.

Good Informatics Practice (GIP)
Our founder, Ford Winslow, pioneered security practices in Life Sciences, giving ICE unique insights into industry needs.

Scalability
From benchtop R&D to bedside applications, we support companies at every stage of development.

Flexibility
Whether operations are in-house or rely on CROs and CMOs, we protect your data and intellectual property.

Quality Alignment
We understand the language of Quality, working seamlessly with QA, QC, Clinical, Research, Back Office, and Commercial teams.

Atom-1--Streamline-Cyber

Partner with ICE for Life Sciences Cybersecurity

Let ICE provide the cybersecurity expertise your Life Sciences company needs to protect data, ensure compliance, and focus on improving patient lives.

Wormhole--Streamline-Cyber

Why Partner with ICE?

At ICE, we bring decades of experience working with public companies. From Sarbanes-Oxley requirements to the latest SEC Cybersecurity Rule, our team, processes, and tools are designed to meet regulatory standards while providing practical, cost-effective solutions. Let us help you navigate these new requirements and manage cyber risk effectively.

Brain-User--Streamline-Cyber
Hexagon Background Element - Version 3-2